Ligand validation:6O4C

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 6O4C designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6O4C_NAD_G_601	94%	3%	0.069	0.97	4.99	1.35	16	4	1	0	100%	1
6O4C_NAD_F_601	94%	3%	0.071	0.969	4.84	1.42	16	7	2	0	100%	1
6O4C_NAD_E_601	93%	3%	0.073	0.968	4.88	1.45	16	7	1	0	100%	1
6O4C_NAD_C_601	93%	3%	0.073	0.966	4.89	1.34	15	5	1	0	100%	1
6O4C_NAD_B_601	93%	3%	0.074	0.967	4.94	1.39	16	6	1	0	100%	1
6O4C_NAD_H_601	92%	3%	0.074	0.965	4.97	1.23	16	5	1	0	100%	1
6O4C_NAD_A_601	92%	3%	0.076	0.967	4.85	1.39	16	5	1	0	100%	1
6O4C_NAD_D_601	89%	3%	0.083	0.962	4.92	1.39	16	5	2	0	100%	1
6O4E_NAD_D_601	87%	3%	0.092	0.964	5.15	1.41	16	6	1	0	100%	0.93
4X0T_NAD_B_601	84%	23%	0.108	0.97	2	1.35	14	6	0	0	100%	1
6O4H_NAD_F_602	56%	3%	0.14	0.912	5.15	1.36	16	5	1	0	100%	0.8
4ZUK_NAD_C_602	43%	30%	0.114	0.907	1.53	1.37	5	4	0	0	61%	0.6136
4ZVY_NAD_B_601	13%	16%	0.193	0.818	1.88	2.02	7	10	0	0	52%	0.413
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.